ArticleCells2022

Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma.

Lefu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.